ArticleRevista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia2018
Late-Stage Diagnosis of Breast Cancer in Brazil: Analysis of Data from Hospital-Based Cancer Registries (2000-2012).
Article in Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Breast cancer and cervical cancer: a comparison of the period before and during the COVID-19 pandemic.BMC women's health · 2024Article
- Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17.Cancer causes & control : CCC · 2024Article
- Comprehensive diagnosis of advanced-stage breast cancer: exploring detection methods, molecular subtypes, and demographic influences - A cross-sectional study.Clinics (Sao Paulo, Brazil) · 2024Article
- [Adequacy of provision of procedures for early detection of breast cancer in the Brazilian Unified National Health System: a cross-sectional study conducted in Brazil and its regions, 2019].Cadernos de saude publica · 2024Article
- Intercontinental comparison of women with breast cancer treated by oncologists in Europe, Asia, and Latin America: a retrospective study of 99,571 patients.Journal of cancer research and clinical oncology · 2023Article
- Frequency and factors associated with delay in breast cancer treatment in Brazil, according to data from the Oncology Panel, 2019-2020.Epidemiologia e servicos de saude : revista do Sistema Unico de Saude do Brasil · 2023Article
- Cervical cancer screening in Brazilian Amazon Indigenous women: Towards the intensification of public policies for prevention.PloS one · 2023Article
- 10-year opportunistic mammographic screening scenario in Brazil and its impact on breast cancer early detection: a nationwide population-based study.Journal of global health · 2022Article
- Determinants of Lack of Access to Treatment for Women Diagnosed with Breast Cancer in Brazil.International journal of environmental research and public health · 2022Article
- Five-year survival rate and prognostic factors in women with breast cancer treated at a reference hospital in the Brazilian Amazon.PloS one · 2022Article
- Practical considerations for expediting breast cancer treatment in Brazil.Lancet regional health. Americas · 2021Review
- Challenge of Incorporating New Drugs for Breast Cancer in Brazil: A Proposed Framework for Improving Access to Innovative Therapies.JCO global oncology · 2021Review
- Inequalities in the burden of female breast cancer in Brazil, 1990-2017.Population health metrics · 2020Article
- Low Overall Survival in Women With De Novo Metastatic Breast Cancer: Does This Reflect Tumor Biology or a Lack of Access to Health Care?JCO global oncology · 2020Article
- Risk factors associated with antineoplastic chemotherapy-induced nausea and vomiting.Revista de saude publica · 2020Article
- Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001-14: a case only analysis.The Lancet. Global health · 2019Article
- Breast Cancer in Men: Clinical and Pathological Analysis of 817 Cases.American journal of men's healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo analyze the time trend and the factors regarding the diagnosis of late-stage breast cancer in Brazil from 2000 to 2012.
methodsWe conducted a retrospective cohort study using data from hospital-based cancer registries. Joinpoint regression was used to analyze the time trends of stage at diagnosis. The risk of late-stage presentation was estimated using multinomial logistic regression.
resultsA total of 170,757 cases were analyzed. The median time from diagnosis to treatment was of 43 days (range: 0-182 days). The percentage of cases with late-stage diagnosis decreased from 2000 to 2002, with an annual percent change (APC) of -6.6% (95% confidence interval [95%CI]: -7.6--5.5%); it increased from 2002 until 2009, with an APC of 1.1% (95% CI: 0.9-1.3%), and remained stable up to 2012. Women with college education (compared with illiterate women) had less chance of having a late-stage diagnosis (odds ratio [OR]: 0.32; 95%CI: 0.29-0.35). The odds were greater among brown women (OR: 1.30; 95%CI: 1.21-1.41) and black women (OR: 1.63; 95%CI: 1.47-1.82), compared with white women. The odds were also higher for women treated in facilities located and in the Northern region of Brazil (OR: 1.23; 95%CI: 1.04-1.45) and in the Midwest (OR: 1.61; 95%CI: 1.34-1.94), compared with those treated in the southern region of the country. Age, histological type, and marital status were some of the other factors that were positively related to staging at the diagnosis.
conclusionAccess to diagnosis of breast cancer is uneven in Brazil, and women with lower socioeconomic status present a greater probability of having an advanced stage at diagnosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.